List of Tables
Table 1. Global Emerging Cancer Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Men
Table 3. Key Players of Women
Table 4. Global Emerging Cancer Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Emerging Cancer Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Emerging Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Emerging Cancer Diagnostics Market Share by Region (2018-2023)
Table 8. Global Emerging Cancer Diagnostics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Emerging Cancer Diagnostics Market Share by Region (2024-2029)
Table 10. Emerging Cancer Diagnostics Market Trends
Table 11. Emerging Cancer Diagnostics Market Drivers
Table 12. Emerging Cancer Diagnostics Market Challenges
Table 13. Emerging Cancer Diagnostics Market Restraints
Table 14. Global Emerging Cancer Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Emerging Cancer Diagnostics Market Share by Players (2018-2023)
Table 16. Global Top Emerging Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emerging Cancer Diagnostics as of 2022)
Table 17. Ranking of Global Top Emerging Cancer Diagnostics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Emerging Cancer Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Emerging Cancer Diagnostics Product Solution and Service
Table 21. Date of Enter into Emerging Cancer Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Emerging Cancer Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Emerging Cancer Diagnostics Revenue Market Share by Type (2018-2023)
Table 25. Global Emerging Cancer Diagnostics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Emerging Cancer Diagnostics Revenue Market Share by Type (2024-2029)
Table 27. Global Emerging Cancer Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Emerging Cancer Diagnostics Revenue Market Share by Application (2018-2023)
Table 29. Global Emerging Cancer Diagnostics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Emerging Cancer Diagnostics Revenue Market Share by Application (2024-2029)
Table 31. North America Emerging Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Emerging Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Emerging Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Emerging Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Emerging Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Emerging Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Emerging Cancer Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Emerging Cancer Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Emerging Cancer Diagnostics Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Emerging Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Emerging Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Emerging Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Emerging Cancer Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Emerging Cancer Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Emerging Cancer Diagnostics Market Size by Country (2024-2029) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Emerging Cancer Diagnostics Product
Table 49. Abbott Laboratories Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Danaher Company Detail
Table 52. Danaher Business Overview
Table 53. Danaher Emerging Cancer Diagnostics Product
Table 54. Danaher Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 55. Danaher Recent Development
Table 56. Agilent Technologies Company Detail
Table 57. Agilent Technologies Business Overview
Table 58. Agilent Technologies Emerging Cancer Diagnostics Product
Table 59. Agilent Technologies Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 60. Agilent Technologies Recent Development
Table 61. AstraZeneca Company Detail
Table 62. AstraZeneca Business Overview
Table 63. AstraZeneca Emerging Cancer Diagnostics Product
Table 64. AstraZeneca Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 65. AstraZeneca Recent Development
Table 66. BD Company Detail
Table 67. BD Business Overview
Table 68. BD Emerging Cancer Diagnostics Product
Table 69. BD Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 70. BD Recent Development
Table 71. Biocept Company Detail
Table 72. Biocept Business Overview
Table 73. Biocept Emerging Cancer Diagnostics Product
Table 74. Biocept Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 75. Biocept Recent Development
Table 76. Illumina Company Detail
Table 77. Illumina Business Overview
Table 78. Illumina Emerging Cancer Diagnostics Product
Table 79. Illumina Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 80. Illumina Recent Development
Table 81. Luminex Company Detail
Table 82. Luminex Business Overview
Table 83. Luminex Emerging Cancer Diagnostics Product
Table 84. Luminex Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 85. Luminex Recent Development
Table 86. NeoGenomics Company Detail
Table 87. NeoGenomics Business Overview
Table 88. NeoGenomics Emerging Cancer Diagnostics Product
Table 89. NeoGenomics Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 90. NeoGenomics Recent Development
Table 91. QIAGEN Company Detail
Table 92. QIAGEN Business Overview
Table 93. QIAGEN Emerging Cancer Diagnostics Product
Table 94. QIAGEN Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 95. QIAGEN Recent Development
Table 96. Thermo Fisher Scientific Company Detail
Table 97. Thermo Fisher Scientific Business Overview
Table 98. Thermo Fisher Scientific Emerging Cancer Diagnostics Product
Table 99. Thermo Fisher Scientific Revenue in Emerging Cancer Diagnostics Business (2018-2023) & (US$ Million)
Table 100. Thermo Fisher Scientific Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Emerging Cancer Diagnostics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Emerging Cancer Diagnostics Market Share by Type: 2022 VS 2029
Figure 3. Men Features
Figure 4. Women Features
Figure 5. Global Emerging Cancer Diagnostics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Emerging Cancer Diagnostics Market Share by Application: 2022 VS 2029
Figure 7. Blood Cancer Case Studies
Figure 8. Prostate Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Lung Cancer Case Studies
Figure 11. Others Case Studies
Figure 12. Emerging Cancer Diagnostics Report Years Considered
Figure 13. Global Emerging Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Emerging Cancer Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Emerging Cancer Diagnostics Market Share by Region: 2022 VS 2029
Figure 16. Global Emerging Cancer Diagnostics Market Share by Players in 2022
Figure 17. Global Top Emerging Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Emerging Cancer Diagnostics as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Emerging Cancer Diagnostics Revenue in 2022
Figure 19. North America Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Emerging Cancer Diagnostics Market Share by Country (2018-2029)
Figure 21. United States Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Emerging Cancer Diagnostics Market Share by Country (2018-2029)
Figure 25. Germany Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Emerging Cancer Diagnostics Market Share by Region (2018-2029)
Figure 33. China Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Emerging Cancer Diagnostics Market Share by Country (2018-2029)
Figure 41. Mexico Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Emerging Cancer Diagnostics Market Share by Country (2018-2029)
Figure 45. Turkey Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Emerging Cancer Diagnostics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Abbott Laboratories Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 48. Danaher Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 49. Agilent Technologies Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 51. BD Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 52. Biocept Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 53. Illumina Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 54. Luminex Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 55. NeoGenomics Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 56. QIAGEN Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 57. Thermo Fisher Scientific Revenue Growth Rate in Emerging Cancer Diagnostics Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed